Is HIMS stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-22, Hims & Hers Health Inc. (NYSE: HIMS) is rated D (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 49/100 at a spot price of $16.02 (-6.04% 1D, market cap $3.76B). Pillar breakdown: Fundamental Cash Engine 15/20, Institutional 13F & Options Flow 5/20, SEC Balance-Sheet Forensics 14/20, FRED Macro Regime Fit 4/20, and Executive Insider Alignment 11/20. Across 1015 tracked Health Care issuers, HIMS ranks #242 in composite RQD confidence.